Similarly, hepcidin, a peptide hormone that seems to modulate the action of ferroportin, has been found to be decreased in AD hippocampi (Raha et al., 2013), while hepcidin’s overexpression in mouse astrocytes protects against β-amyloid-induced neurodegeneration (Zhang et al., 2020). This evidence concerns the gene HAMP and Alzheimer disease.